The Supporter Prospectus will be available soon.

Following the success of the sold out 2026 event in San Diego, the 2027 program will once again provide a unique opportunity to hear about the future of oncology drug development from leading pharmaceutical and biotechnology companies. This oncology-focused event will bring together researchers and industry partners to share innovation strategies for drug development and present venture capitalists and investors with new partnership and licensing opportunities to advance these concepts.

AACR is committed to facilitating innovation through translational science—turning clinical observations and early scientific discoveries into actionable insights and patient interventions more efficiently. By bridging the gap between cancer research, pharma, and patients through innovation and collaboration, this event provides a platform for the advancement of key relationships in the biopharmaceutical industry, with the goal of ultimately bringing discoveries closer to patients.